"What we've shown for the first time is that there is a hierarchy of enhancers—some act as master switches... while others are more compensatory."
— Suhn Kyong Rhie, PhD, corresponding author
Master Switches Discovered in Prostate Cancer's Genetic Network
A new study published in Genome Biology reveals that enhancers in prostate cancer cells form a hierarchical 3D network, with some acting as central hubs that control multiple genes while others play supporting roles. Critically, deleting these central "master" enhancers disrupted the network, reduced cancer-promoting gene activity, and slowed cancer cell growth.
Using 201 datasets from prostate tumor and healthy tissue samples, researchers identified 3,216 key enhancers specific to prostate cancer. They then mapped enhancer-gene interactions using Region Capture Micro-C and CRISPR technology, testing the effects of deleting individual enhancers.
Key Findings
- Deleting some enhancers had little effect on the network.
- Deleting central "hub" enhancers significantly reduced the activity of other enhancers and suppressed cancer cell growth.
Implications for Future Therapies
The findings suggest a potential for gene-editing therapies that target these master enhancers. However, the authors caution that further research is needed to address potential side effects.
Background
Enhancers are DNA sequences that regulate gene expression. This study adds to the growing understanding of non-coding DNA, which was once dismissed as "junk DNA."
The study was supported by the NIH, Department of Defense, and the USC Norris Comprehensive Cancer Center.